SPECTARIS seminar where we share some of our business acumen


On the 23rd of September from 09:30 – 11:00 am CET, I will speak, together with Dr Kuboniwa from the JBA (Japan Bioindustry Assn) and Mr Kosuge from JETRO. The over-arching theme is: Analytical-, Bio- and Laboratory Technologies: Market and distribution opportunities for German manufacturers in Japan

It will be a well-invested one-and-a-half-hour if you are a manufacturing company in the pharma industry and looking at Japan as a potential new market or if Japan is a market you want to achieve more traction in.

I will share: Highly useful and pragmatic tips and three enlightening case studies from reality. I will also tell you how you, if you are an SME, can benefit from German’s RKW.

Come, enjoy, learn and ask questions!

Official invitational flyer (PDF) you find here

Sign up to the event here!

Iris Biotech – an exemplary performance of how to do business in Japan

Thomas Bruckdorfer in Japan

In 2001, Iris Biotech GmbH was founded in the Bavarian city Marktredwitz close to the Czech border. Just one year later, the company started doing business in Japan to promote its unique portfolio. Quite successfully so! We were very lucky to get the opportunity for an interview with their CSO, Thomas Bruckdorfer, who is also one of the two partners behind this successful enterprise. Herein, he shares some of his experiences gained during this fruitful journey.  

Iris Biotech follows the slogan: 

Empowering Peptide Innovation 

In the beginning, the company mainly focused on peptides as well as substances for the synthesis therof, which still represents the core business of Iris.  

Today, they expanded the portfolio towards reagents for Drug Delivery, LifeSciences and Diagnostics. 

Yes, our company’s focus remains Peptide Chemistry. But during the years we have also gained strong expertise in Drug Delivery, Life Sciences and Custom Syntheses. This is the know-how which we are sharing with our customers. We support scientists in both industry and academia with standard consumables as well as innovative and rare compounds.

Iris Biotech also supplies Amino Acids, Resins, Reagents and Solvents.

– Besides, our portfolio contains a great variety of substances for Drug Delivery including mono- and polydisperse PEGs as well as various polyamino acids. Especially the latter ones are attractive tools as they represent biodegradable alternatives to PEGs, which help to improve the solubility and pharmacokinetic properties of peptides, proteins, biopharmaceuticals and organic drug molecules. 

– In this context, I would like to mention our newly evolved field of activities, the so-called Linkerology, which advanced during the last few years. First mainly in the USA, now also in Europe and in Japan – more and more applications are coming up, where small highly potent molecules need to be conjugated to targeting vehicles, like antibodies. Designing linkers, which carry payloads safely through the plasma and degrade in a self-immolating manner inside cancer cells only, has become a sophisticated and challenging business field, both from a scientific and also commercial point of view. 

Your latest addition to your portfolio, the Life Sciences and Diagnostics, is it still the smallest part of what you do? 

– Smallest, yes, nonetheless an important part of our portfolio. We provide substrates, metabolites, inhibitors and inducers, natural products with biological and pharmacological activity, as well as dyes and fluorescent labels that are used as tools in immunology, biochemistry and molecular biology. We add innovative compounds on almost a daily basis. As an example, one of them, the Indocyanine Green (ICG), is an FDA approved dye, which is accepted for applications in human.

With a catalogue of some 7000 products and adding up to a hundred new compounds every month, Iris Biotech is a treasure throwe for scientists and manufacturers in the wide fields of biotech. As the biopharma manufacturing industry is moving towards personalized medicine, have you seen it impact your business?

– Yes, of course! We see a growing demand for tailor-made compounds and solutions. As a result, we reinforced our Custom Synthesis capabilities in 2013. We want to support our customers in their needs and I’m happy to say that we offer profound expertise in custom manufacturing of complex compounds, such as rare chiral building blocks, sophisticated orthogonal protecting groups, heterocycles, PEGs and PEG-analogues. 

How has Covid-19 impacted your business?

– We basically have two types of customers: the industry and academia. As universities have pretty much had no activity in the latest months, their procuring of substances from us has, of course, dwindled. However, because of the same reason, Covid-19, our industrial customers are putting a lot of effort into fighting this new disease, meaning they procure more from us than ever before. On the whole, we basically have business as usual. Besides that many have turned to us from the cheapest possible sources, because they appreciate our sustainable approach of maintaining the supply of high-quality compounds, still within reasonable pricing.

You entered Japan in the year of 2002. What were your thoughts and impressions on Japan prior to that? 

– Businesswise, we have never had any issues in Japan. All countries have their certain local characteristics and still are more or less the same when it comes to doing business. If you are well prepared, you will be rewarded. For Japan, we collected as much information in advance as we could concerning potential partners, customers and business culture. I felt very well prepared because we knew the players, the KOL’s, we had started to network and we had decided upon our strategy. 

How do you think Japan is different from other markets and how often do you travel to Japan? 

– In a way, Japan is not different from any market. If you try to do business in the USA and haven’t prepared well, it is going to be problematic for you. Same thing for any market: if you don’t know how your business area operates and how to do business, then you will not succeed. The Japanese market represents a decent part of our total sales. In a typical year, I travel there a couple of times, usually stay for two weeks which gives me the opportunity to enjoy the unique cultural heritage and Japanese atmosphere, food culture, and saké. You know, the things I can’t enjoy at home. Japan has definitely become one of my favourite places to go to. 

– One of the biggest hurdles, I would say, is besides language barriers the impracticalities of timezone differences. This is another reason, why you need a local partner for doing business efficiently and successfully. 

When it comes to being successful when exporting to Japan, what are your best tips for the ones coming after you? 

– Make sure you are working with local personnel, who are your partners. It is important – as everywhere on this globe – to listen accurately to your partners and being open to adapt to the local requirements. I have experienced that people are in general very friendly, nevertheless tell you openly and clearly, what is required and what needs to be changed and adapted! That is probably the most important thing, which I found to be true also for every other place in the world.  

One problem that is plaguing many Europeans is their weakness when it comes to actually sell and strut your stuff. How do you sell? 

– We follow our focus, always: Empowering Peptide Innovation. With this guiding theme in mind, we attend the right conferences, symposia and exhibitions every year. This allows us to remain in direct contact with our existing and future customers as well as the KOL’s of the industry. We exchange knowledge and gather new ideas to tackle the customer’s current challenges. This dialogue with the industry and academia automatically leads to new and increased sales for us. It’s important to engage in a dialogue that is useful. 

With this, we say thank you to Thomas Bruckdorfer, CSO of Iris Biotech GmbH in Germany. 

Iris Biotech GmbH is a renowned, globally active company for innovation and know-how in the field of pharmaceuticals and biotechnology. Starting in 2001 with a small range of commodities for peptides, Iris Biotech meanwhile developed its portfolio to a unique list of standard reagents and unusual building blocks for various life science applications. Our custom synthesis products as well as our portfolio in drug discovery, drug delivery, and diagnostics are available in laboratory quantities for the research sector up to multi ton scales. Those capabilities highlight Iris Biotech GmbH as valued partner for your success.

Having a holistic view of the world of peptides, Iris Biotech GmbH is today the number one address for any unusual compound required for the modification of peptides. Our mission as qualified supplier is to support customers in their ongoing projects from research scale to commercial production by providing the most novel substances and latest technologies together with the required analytics and documentation.

REad more on Iris biotech’s homepage, here!

SARS upgraded evil twin SARS-CoV-2, a business devastator and heroes creator

SARS-CoV-2 infographics

It is in times of adversity that people and organizations show what they are really made of. In Japan, schools are closed, just like many museums, most or all trade shows have been cancelled or postponed, with many people sick and dying. Some products have seen manifold price-hikes with the follow-up dialogue if that’s in any way ethically defendable. In the meantime, the virus continues to spread. And not only in Japan. It’s everywhere! This article aims to shine a light on some who are truly heroes. This article is sourced and cross-checked over a vast number of sources meaning that it’s hopefully close to true.

The latest threat to global health is the ongoing outbreak of the respiratory disease that was recently given the name Coronavirus Disease 2019 (Covid-19).

New England journal of medicine

Doing business in times of pandemics

It’s generally believed that a bad pandemic will remove 5% of the global economy. Depending on the nature of the outbreak, different industries will, of course, be affected differently. It is true that even in the worst of times, there are business opportunities.

The travel and tourism industry is generally suffering. Other sectors that are taking a hit include events, restaurants, retail, leisure and real estate.

The gold price hit a seven-year high last week and stock markets around the world plunged. The Dow Jones Industrial Average suffered its worst week in over a decade as investors apparently shifted from ignorance of an impending pandemic into PPM: Panic-Pandemic-Mode. Put in a different light, last week wiped out a full year’s worth of market gains.

The Summer Olympics may not happen, Saudi Arabia shut down many religious sites and in South Korea, the leader of one church may face charges on manslaughter and their president Moon Jae-in is facing possible impeachment after earlier stating that the coronavirus will soon disappear. The media is also reporting that Panic Buying has started in Australia.

Drug companies are racing to develop or repurpose treatments to combat the potential pandemic. There are currently 35 active drug development programs in North America, Europe, and China.

A new survey by Genetic Engineering & Biotechnology News (GEN

Hard times make heroes

One great example is the British company Cambridge Mask who produces military-grade face masks for ordinary people. Their business has gone through the roof and they have slashed the price on-line with 10%.

“I’m pleased someone is appreciating that we’re not raising our prices. It seems a much more socially responsible thing to do in this situation.”

CEO of Cambridge Mask, Christopher Dobbing


…while several companies in hand-sanitation and mask-production have doubled (or more) their prices.

Amazon is warning third-party sellers against exorbitant price hikes to face masks as it’s a violation of their Fair Pricing Policy. It seems Amazon has warned some vendors, but not yet banned any sellers.

The biggest hero is, of course, the Chinese whistleblower Li Wenliang who was shut up by the Chinese authorities and then became a victim of the disease he had discovered. However, all the healthcare workers of the World easily qualify for the heroes list.

COVID-19 in Japan

Apart from the unbelievably clumsy incompetence shown regarding the management of the infection spread onboard the Diamond Princess ship, there is a deep and serious discourse in society.

In late February, Japan’s prime minister Abe called for the closure of all Japanese elementary, junior high, and high schools as a measure to help slow the spread of the coronavirus. Many festivals and events such as trade shows like MEDTEC 2020 in Tokyo have been cancelled or postponed. Also, theme parks such as Tokyo Disneyland, Tokyo DisneySea, and Universal Studios Japan, museums and galleries have been closed until further notice.

Japanese huge advertising company Dentsu sent 5,000 workers to work from home after one employee tested positive for the virus. Cosmetics group Shiseido decided that 8,000 employees should start teleworking. A growing number of Japanese companies are cutting most or all business-related travel and looking at various ways to. Business meetings are also increasingly moved to online platforms.

Already the old Greeks…

Let’s go back to September of last year, 2019. An article published by Foreign Policy then says what we’ve all actually known all along, that our life on Earth is under serious threat from a horrific pandemic. The question isn’t “IF” but “WHEN”. A bad pandemic can kill 80 million people and wipe out a huge portion of the global economy. That’s a serious threat to modern society, something that WHEN it happens, the World will never fully recover from. The Secretary-General of the United Nations, the World Bank and other prominent organizations were the source of this statement. Read it! It’s important!

Even if the World has many brilliant scientists and leaders that have been trying to make governments prepare for the next bad pandemic since over 100 years ago, not much has actually happened regarding preparation. As you could see from the many disastrous and crazy mistakes made by health professionals in Japan with the ship Diamond Princess. It’s extra scary as Japan is likely the World’s best-prepared nation for anything that threatens society or infrastructure.

Our biggest hero is, of course, Dr Li Wenliang who first found the virus, sounded the alarm and was immediately silenced by the authorities in China…

“Denial is not just a river in Africa.”

As the saying goes…

Italy, Iran and Korea are three other nations that are competing with China and Japan on ineptitude, bad preparations, bad luck and bad policies. Before long, there will be many more countries added to this pitiful list. Even if China is trying hard to look like the World leader in fighting COVID-19, the facts remain that the Chinese government silenced whistle-blowers, withheld information and downplayed the threat, allowing for the early stages of this epidemic to go unchecked rather than being dealt with.


Do you remember the SARS outbreak in 2003? SARS: Severe Acute Respiratory Syndrome. It’s a Coronavirus and it affected over 8000 people in 26 countries and took 6 months before it was finally contained. The containment could happen primarily because patients only became contagious after one week of being sick. Now we are meeting with SARS’ upgraded evil twin: SARS-CoV-2. This new SARS is contagious before patients become sick and have already affected over ten times (!) as many people in half the time. Containment of the new virus has not yet been successful and it seems that the only thing we can do is to slow down its spread.

The dangers of being alive

If you compare the number of yearly deaths for different reasons, the COVID-19 number of deaths is almost insignificantly small, hardly even a blip on the screen:

Deaths per year:
Ordinary seasonal flu: up to 500,000 dead
SARS: 774 people dead in 6 months.
SARS-Cov-2: Just under 3,000 people dead in 4 months
Dengue fever: 25,000 people
Malaria: 800,000 people  (2018)
HIV: 770,000 people (2018)
TBC: 1,500,000 people in 2018 (including 250,000 people with HIV)
Measles: 140,000 deaths, mainly in young children

However, if the pandemic explodes, as many diseases have done in history, we will be looking at death tolls in the vicinity of the Spanish flu or the Black Death.

Spanish flu: 50,000,000 deaths
Black Death: 100,000,000 deaths

It’s also useful to look at some other common reasons for deaths among people on this planet:

Road Traffic Deaths: 1,250,000 deaths
Smoking: 7,000,000 deaths
Obesity: 2,800,000 deaths
Alcohol: 3,000,000 deaths

A bad pandemic will take more lives than all of these deaths combined!

It will be disastrous if SARS-CoV-19 kills as many people as the Spanish flu did. It is a terrible possibility and a scenario we need to be prepared for.

But why wasn’t this heard and all necessary precautions put in place already after the Spanish flu in 1920?

…and why only now, as the virus says: “told-you-so”? Denial may be one important explanation model. “Not-recently-seen-in-my-backyard” may be another important factor as to why so little preparation has actually been executed. For instance, Sweden woke up only yesterday.

What is a typical (?) politicians way of thinking: “If I push on the popular issues instead of the boring and expensive long-term issues, I can be re-elected.” And the typical voter’s way of thinking: “I want what is good for me and I want it now!” Our political systems usually suffer from shortsightedness. This is because it’s quite risk-free to wager that something bad that didn’t happen in the last 15 years, also won’t happen in the near future.

It also seems that the organizations against CO2 and other issues on the top of the agenda are screaming so loud that not much else gets through for those “not-in-the-know” of microorganisms, virus and disease. Not saying that we should not make efforts to keep our planet healthy, but we need to balance it with keeping people healthy as well.

Luck runs out

The very real and the very dangerous recent outbreaks of SARS, MERS and Ebola, to mention a few, should have sounded everybody’s alarm clocks. Those outbreaks managed to be contained, a lot thanks to sheer luck. However: Luck runs out. The SARS-CoV-2 is maybe the villain that beats humankind’s lucky streak?

Juicy headlines tend to be the foundation for both private and political decisions. Unfortunately, this isn’t so for facts.

Healthy humans on a healthy planet

Imagine if we halved our financial efforts with the CO2 issues and instead invested that money in preparing for pandemics and fighting infectious disease. Simply put, it means curing and getting rid of HIV, TBC, Measles, Polio, Dengue, Malaria, Zika and the other main killing infectious diseases. If we decided to do this, we could actually do it. Compared to other issues, the solutions are quite affordable. Before the year 2100, we could then have saved 250 million lives plus massively impaired the death toll of future pandemics. This further means we would vastly improve life expectancy and quality of life for all people on this planet. It is possible that climate change could curb those positive effects to some degree, but not very much.

A terrible truth is that alarmingly few long-term precautions have been taken by governments even in the light of the recent years’ close calls. However, we can also put the blame on ourselves for not help to make the fight against microorganisms and virus a global key priority.

If COVID-19 spreads globally and deeply into all populations: It will almost surely affect how we all live our lives for the next 6 months or so, it will almost certainly kill some of our near and dear, and the Coronavirus will almost certainly continue to disrupt business on a grand and global scale.

Let’s get back to basics:

What’s a Pandemic?

Such a Jeopardy answer, of course, follows the statement: an epidemic disease that is spreading across multiple continents, or worldwide.

Flu pandemics are generally excluded from this definition as they are thought of as recurrences of seasonal flu. Throughout history, there have been a big number of pandemics, such as smallpox, leprosy and tuberculosis. One of the most devastating pandemics was the Black Death in the 14th century, which killed an estimated 100–200 million people. The only current pandemic is HIV/AIDS, which started in the 1980s. Other recent pandemics include the 1918 influenza pandemic (Spanish flu) and the 2009 flu pandemic (H1N1).

…and now it seems we may soon add COVID-19 to the ugly list of pandemics…

So that we don’t forget: Ebola, SARS, MERS, Zika, Bird flu and others have come very close to becoming bad pandemics. But, heroes worked hard and … humankind was also lucky.

Pandemic – Endemic? What’s the difference?

It is important to remember that widespread disease can also be endemic (meaning in a steady-state, not increasing in the number of affected people) like chickenpox in Europe. It’s a disease that is stable in terms of how many people are getting sick from it. Endemic doesn’t count as a pandemic.

Among the endemic diseases plaguing us, we find terrible members such as TBC, Malaria, Leprosy, Measles, STD’s and the whole alphabet of Hepatitis.

What are we seeing with the new Coronavirus, the SARS-CoV-2?

We may very well be witnessing the onset of a bad pandemic at this moment in time. SARS-CoV-2 is obviously a deadly viral disease that we so far have not been able to contain. How deadly the virus is, is not known yet, but it’s fair to assume that it’s more deadly than the average seasonal flu. It clearly is much more dangerous the older you are and if you have other complications. Many governments, ministers and ordinary people still seem to be perplexed or in denial, possibly hoping for this nightmare to go away auto-magically. Hoping and worrying are both useless because reality needs to be dealt with.


The difference between anti-waxers and flat-earthers is that the flat-earthers in a worst-case-scenario can contribute to confusing other, sane, people. On the other hand, the anti-waxers pose a real danger to themselves, their children and society. That’s because they allow really dangerous bugs to continue circulating in society for a number of silly and non-scientific ideas.

As we still don’t have a vaccine for this new virus, it means that us ordinary people will fare as poorly as the anti-waxers. To be as poorly prepared as the anti-waxers and to die in equal proportions is a terrible thing. The balance is usually heavily skewed towards the anti-waxers doing the main-part of the dying.

Do you remember from your history lessons that the Catholic Church were among the first and strongest anti-waxers after Jenner invented vaccination for smallpox by inoculating cowpox in people? Their argument: Humans shouldn’t meddle in God’s affairs, and it’s only good that we humans suffer, as suffering brings us closer to God. That’s quite a tricky one to translate into an ethical statement.

It’s much more straightforward to argue the ethical correctness in preferring the heroism of the people and organizations that sequenced the SARS-CoV-19 virus genome, that have made their databases available in the public domain, produce SARS-CoV-19 vaccines and look for antivirals. Can’t help putting the hero-sign up also on Sharp’s initiative to start mass-production of facemasks in a TV factory.

“Heroes are heroes because they are heroic in behaviour, not because they won or lost.”

Nassim Nicholas Taleb

Sources: The New England Journal of Medicine, World Bank, Foreign Policy, New York Times, Japan Travel, Financial Times, Vox, BBC, In-Pharma Technologist, The Verge, The Guardian, Wired, Wikipedia, CNBC, Genetic Engineering & Biotechnology News (GEN), McKinsey and WHO.

Suggested further reading

Closed attractions in Japan, updated list here.

BBC All about the Novel Coronavirus

VOX The travelguide for Coronavirus times

If you want to be really scared, check out this TED Talk on How synthetic biology could wipe out humanity — and how we can stop it by: Rob Reid.

Coming soon: The podcast on doing business in Japan

Podcast Japan - What could possibly go wrong?

Japan – What could possibly go wrong?

We are soon launching our podcast. There are some technical issues that remain. We have a great lineup of amazing people sharing their views, experiences and insights with you on doing business in Japan.

Focus is on how to make your business grow in Japan, mistakes that great people have made in Japan and some amazing gems on how to grow as a human being.

Our amazing friends share not only their success stories but also their mistakes and shortcomings. This adds up to a lot of things to learn and to enjoy!

Stay tuned and buckle up! There are great lessons to be learned!

Our first interview is with Calle Eklund, Swedish national and CEO of Hoganas Japan K.K.

Calle Eklund, CEO of Hoganas Japan K.K. in his friendly office in central Tokyo.

Stay tuned!

Relaunch ! ! !

The new beginning for our homepage

Our homepage fell victim to hackers in the end of 2019. As useless as the attack feels, it taught us some important lessons regarding backups and the extent of our own responsibility. Hopefully, this means we’ve learned how to deal with and to mitigate the things that are not predictable and have very little bearing with doing business.

It has taken us some time to create our new page, but here it is!

From now on, we will follow our safety protocols and regularly update plugins with regular virus and malware scans PLUS regular complete backups that we never delete.

Let 2020 be great and safe!